GTBP icon

GT Biopharma
GTBP

Overview Fund Trends Analyst Outlook Journalist POV

34 hedge funds and large institutions have $4.36M invested in GT Biopharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

87% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 15

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$58K
2
+$44K
3
+$35.2K
4
Goldman Sachs
Goldman Sachs
New York
+$25.3K
5
State Street
State Street
Massachusetts
+$15.3K

Top Sellers

1
-$242K
2
-$193K
3
-$183K
4
Citadel Advisors
Citadel Advisors
Florida
-$182K
5
Millennium Management
Millennium Management
New York
-$159K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
27
$1K
28
$1K
29
$1K
30
$1K
31
$25
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
1
2